Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection

BACKGROUND: Sequential addition of tenofovir disoproxil fumarate (TDF) is often needed for patients coinfected with HIV and hepatitis B virus (HBV) who develop HBV resistance to lamivudine after combination antiretroviral therapy (cART) containing only lamivudine for HBV. We aimed to assess the viro...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yu-Shan, Chang, Sui-Yuan, Sheng, Wang-Huei, Sun, Hsin-Yun, Lee, Kuan-Yeh, Chuang, Yu-Chung, Su, Yi-Ching, Liu, Wen-Chun, Hung, Chien-Ching, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5199102/
https://www.ncbi.nlm.nih.gov/pubmed/28033344
http://dx.doi.org/10.1371/journal.pone.0169228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5199102/
https://www.ncbi.nlm.nih.gov/pubmed/28033344
http://dx.doi.org/10.1371/journal.pone.0169228

Ejemplares similares